The transforming growth factor-b (TGF-b)-Smad signaling pathway inhibits the growth of human epithelial cells and plays a role in tumor suppression. The Smad4 gene is mutated or deleted in 50% of pancreatic cancers. In this study, we succeeded in establishing Smad4 knockdown (S4KD) pancreatic cancer cell lines using the stable RNA interference (RNAi) method. Smad4 protein expression was reduced dramatically and TGF-b-Smad signaling was markedly inhibited in the S4KD cell lines. The S4KD and control cells were stimulated with TGF-b and analysed using a cDNA microarray that contained 3756 genes, in order to screen for target molecules downstream of TGF-b. The microarray analysis revealed that 187 S4KD genes and 155 genes in the control cells were regulated immediately upon TGF-b stimulation. Quantitative RT-PCR analysis on several of these genes produced results that corroborated the outcome of the microarray analysis. Most of the genes in the S4KD and control cells identified by the array differed, which suggests signaling pathways that differ according to Smad4 status. Of the identified genes, 246 have not been reported previously as genes that lie downstream of TGF-b. Genes that are involved in cell proliferation, adhesion, and motility were found to be regulated differentially with respect to S4KD and control cells. Cell migration induced by TGF-b was inhibited in the S4KD cells, which might be associated with a different regulation of integrin b7. The knock down of a specific gene using stable RNAi appears to be a promising tool for analysing endogenous gene function.
The transforming growth factor-b (TGF-b)-Smad signaling pathway inhibits the growth of human epithelial cells and plays a role in tumor suppression. The Smad4 gene is mutated or deleted in 50% of pancreatic cancers. In this study, we succeeded in establishing Smad4 knockdown (S4KD) pancreatic cancer cell lines using the stable RNA interference (RNAi) method. Smad4 protein expression was reduced dramatically and TGF-b-Smad signaling was markedly inhibited in the S4KD cell lines. The S4KD and control cells were stimulated with TGF-b and analysed using a cDNA microarray that contained 3756 genes, in order to screen for target molecules downstream of TGF-b. The microarray analysis revealed that 187 S4KD genes and 155 genes in the control cells were regulated immediately upon TGF-b stimulation. Quantitative RT-PCR analysis on several of these genes produced results that corroborated the outcome of the microarray analysis. Most of the genes in the S4KD and control cells identified by the array differed, which suggests signaling pathways that differ according to Smad4 status. Of the identified genes, 246 have not been reported previously as genes that lie downstream of TGF-b. Genes that are involved in cell proliferation, adhesion, and motility were found to be regulated differentially with respect to S4KD and control cells. Cell migration induced by TGF-b was inhibited in the S4KD cells, which might be associated with a different regulation of integrin b7. The knock down ofIntroduction Smad4 is a key mediator of transforming growth factorb (TGF-b)-Smad signaling, which is known to inhibit epithelial cell growth. Formation of a heteromeric complex between the TGF-b ligand and the TGF-b type I and type II receptors (TbRI and TbRII) leads to phosphorylation of the cytoplasmic Smad2 and Smad3 proteins by the activated TbRI kinase, which, in turn, allows the formation of a heteromeric complex with Smad4. Smad4 is the only mammalian form of the common mediator Smad (Co-Smad); the cytoplasmic Smad oligomer is translocated into the nucleus, where it regulates TGF-b-responsive gene transcription in cooperation with transcription factors and other cofactors (reviewed in Miyazono et al., 2000; Derynck et al., 2001) .
Impairment of the Smad pathway results in escape from growth inhibition and leads to the promotion of cell proliferation, thereby contributing to carcinogenesis. Various genetic and epigenetic alterations of the components of the Smad pathway have been identified in several human cancers (Markowitz et al., 1995; Hahn et al., 1996; Schutte et al., 1996; Togo et al., 1996; Miyaki et al., 1999; Wang et al., 2000) . Mutation or deletion of the Smad4 gene, which was originally designated as the tumor suppressor gene DPC4 (deleted in pancreatic carcinoma, locus 4), has been detected in 50% of all pancreatic cancers , and we have reported previously that many pancreatic cancer cell lines have impaired TGF-b-Smad signaling, due to a functionally inactivated Smad4 (Ijichi et al., 2001) .
The TGF-b signal is also transduced through the Smad-independent pathway (Bhowmick et al., 2001; Yu et al., 2002) , and appears to promote tumor progression under certain conditions (Derynck et al., 2001) . However, the characteristics and significance of the Smad-independent signaling pathway remain unresolved. Since increased expression of TGF-b is often detected in tumors, including pancreatic cancers (Derynck et al., 1983; Friess et al., 1993) , it is possible that these tumors develop in a cell-autonomous manner via the TGF-b-induced, Smad4-independent pathway.
RNA interference (RNAi) is an evolutionarily conserved mechanism of gene silencing. Recently, 21-to 23-nucleotide double-stranded RNA (short interfering RNA, siRNA) molecules have been shown to exhibit specific RNAi effects without inducing the host defense system (Elbashir et al., 2001) . Although the effect of siRNA that is introduced transiently into cells is restricted because of low transfection efficiency or the short-term persistence of silencing effects, we, and others, have reported recently that a plasmid vector that expresses siRNA enables long-term persistence of the silencing effect, a phenomenon that is termed 'stable RNAi' (Brummelkamp et al., 2002; Miyagishi and Taira, 2002) . This system represents a powerful tool for analysing endogenous gene silencing.
In this study, we established Smad4 knockdown (S4KD) pancreatic cancer cell lines using the stable RNAi, subsequently investigated the Smad4-independent target genes downstream of TGF-b and phenotypic changes due to the S4KD.
Results and discussion

Establishment of S4KD pancreatic cancer cell lines
In order to mimic the genetic characteristics of inactivated Smad4 in clinical pancreatic cancer, we knocked down the Smad4 gene in the human pancreatic cancer cell line PANC-1, which has a functional TGF-bSmad signaling pathway (Grau et al., 1997; Ijichi et al., 2001 ). First, we constructed plasmids that expressed short hairpin RNAs that were targeted against Smad4 under the control of the U6 promoter (pcPUR þ U6-Smad4i) (Figure 1 ) as described previously (Miyagishi and Taira, 2002; Yokota et al., 2003) . Five different sequences were originally selected for targeting the Smad4 gene (Supplementary Table 1) .
Second, we transiently transfected PANC-1 cells with pcPUR þ U6-Smad4i and the Smad4 protein expression vector, and examined Smad4 protein expression by Western blotting. As shown in Figure 2a , the site 5 plasmid (lanes 3 and 4) was the most effective at blocking Smad4 protein expression, and was employed in subsequent experiments.
Then, PANC-1 cells were transfected with pcPUR þ U6-Smad4i (site 5) or pcPUR þ U6icassette (control vector), and incubated with 2 mg/ml puromycin (WAKO, Osaka, Japan), to select puromycin-resistant single clones and cell pools, which were mixtures of the puromycin-resistant polyclonal cells. Thus, we obtained S4KD and Smad4 intact (control) cell lines, which are designated as PANC-1-S4KD and PANC-1-puro, respectively. For the sake of convenience, the PANC-1-puro cells are termed the WT cells. As shown in Figure 2b , most of the PANC-1-S4KD clones (lanes 1-5) and cell pools (lanes 11 and 12) exhibited a dramatic knock down of Smad4 protein expression.
There are three isoforms of TGF-b, called TGF-b1, -b2, and -b3, with similar biological functions. We performed further experiments using TGF-b1 as the ligand in this study. Luciferase assays using the Smaddependent reporter (CAGA) 9 -luc showed that the canonical TGF-b-Smad-dependent signaling was markedly inhibited in the S4KD cells (lanes 2-6), which indicates a functional S4KD (Figure 3) .
Besides, we performed several quantitative RT-PCR to confirm the status of S4KD. In the following experiments, we used the PANC-1-S4KD and WT cell pools, to avoid deriving from the specificity of a single clone. Total RNA was extracted from the S4KD and WT cell pools that were incubated with or without 10 ng/ml of TGF-b1 for 2 h. Initially, we examined the status of the Smad4 mRNA. Analysis of the S4KD and WT cells that were incubated without TGF-b revealed that Smad4 was downregulated in S4KD cells, as compared to WT cells (Figure 4a) .
Recently, it has been suggested that siRNA crossreacts with nontargeted genes that contain sequences with homology to the siRNA (Jackson et al., 2003) . To exclude this type of phenomenon, we used quantitative RT-PCR to examine the expression of the DCP1 (dipeptidyl carboxypeptidase 1) gene, which has a similar sequence to the siRNA that was targeted to the Smad4 gene. The PANC-1-S4KD and WT cell pools showed almost identical DCP1 mRNA expression, which confirms the specificity of the S4KD in the S4KD cells ( Figure 4b ).
Next, we examined the expression of major Smaddependent target molecules. Plasminogen activator inhibitor-I (PAI-I) is an extracellular matrix-associated protein, which is regulated in a Smad4-dependent manner (Hocevar et al., 1999) . Smad7 is an inhibitory Smad, which is upregulated by TGF-b and forms a negative feedback loop (Miyazono et al., 2000) . The WT cells showed PAI-I and Smad7 upregulation in response to TGF-b1. Conversely, induction by TGF-b1 diminished in the S4KD cells (Figure 4c The PANC-1-S4KD and WT cells were transfected with (CAGA) 9 -luc and pRL-SV40. After 24 h, the cells were incubated with or without 2.5 ng/ml TGF-b1 for an additional 24 h, and the dual luciferase assay was performed. The firefly luciferase activity of (CAGA) 9 -luc was normalized to the Renilla luciferase activity of pRL-SV40. The level of luciferase in cells in the absence of TGF-b1 was assigned a value of 1.0, and the relative activities were calculated. The experiments were performed twice in duplicate, and the mean and standard deviation (s. RT-PCR in this study are shown in Supplementary  Table 2 .
Thus, we succeeded in establishing S4KD pancreatic cancer cell lines. The stable RNAi method is considered a powerful tool for analysing the 'loss of function' of endogenous genes.
Target genes regulated by TGF-b1 in the S4KD and Smad4 intact cells
We investigated the downstream molecules that are regulated by TGF-b signaling in the S4KD cells, with the aim of developing novel target molecules or therapeutics for pancreatic cancer, which is a disease with a poor prognosis. Total RNA was also extracted from PANC-1-S4KD and WT cell pools that were incubated with or without 10 ng/ml of TGF-b1 for 2 h. We adopted the 2-h incubation in order to detect the putative direct target genes of TGF-b, the transcription of which is regulated immediately upon stimulation.
We analysed the comprehensive gene expression profiles that were induced by TGF-b1 stimulation of the S4KD and WT cells, using a microarray that contained 3756 individual genes. Comparisons of the array data in the presence and absence of TGF-b1 led to the identification of TGF-b-regulated target gene clones that showed >2-fold increases or o0.5-fold decreases in expression following TGF-b1 stimulation. The genes that belong to these categories are listed in Tables 1 and  2 and Supplementary Table 3 .
To confirm the microarray data, we performed quantitative RT-PCR analysis on several of the genes that were obtained from the microarray. As shown in Figure 5 , the RT-PCR results matched those of the array, which indicates the reliability of the detection of target genes, although less fold changes were observed in the RT-PCR than in the array in this study. The list includes those genes whose expression was upregulated >2-fold or downregulated o0.5-fold by TGF-b1. The 20 highest and the 20 lowest expressed genes are shown Figure 5a showed the examples of target genes from the S4KD cells. In the microarray the fold increase of nucleoporin 153 kDa was 17.2, dynein, axonemal, heavy polypeptide 2 was 7.30, and SUMO-1-activating enzyme subunit 2 was 2.28 in the S4KD cells, respectively. Some of the clones obtained from the S4KD array showed similar patterns of TGF-b1-mediated regulation in both the S4KD and WT cells, which suggests that certain Smad4-independent target genes are common to both cell types (Figure 5a) . Figure 5b showed representatives of target genes from the WT cells. In the microarray, the fold change of caspase-3, apoptosis-related cysteine protease was 2.32, karyopherin alpha 6 (importin alpha 7) was 2.03, and of potassium large conductance calcium-activated channel, subfamily M, beta member 1 was 0.422 in the WT cells, respectively. The clones from the array of WT cells were regulated in a similar manner to that seen for the WT microarrays, but were not regulated in the S4KD cells, which indicates that Smad4-dependent targets are regulated only in Smad4 intact cell lines (Figure 5b) .
Although the WT cells were expected to contain both the Smad4-dependent and -independent signaling pathways, they showed lower numbers of target genes than the S4KD cells. This suggests that there were more targets for TGF-b in Smad4 intact cells, especially in the Smad4-independent pathway.
Although the number of target genes in the WT cells may have been underestimated, we identified 320 clones of target molecules for TGF-b1 in this microarray analysis. In the S4KD cells, 120/3756 clones were upregulated and 67/3756 clones were downregulated by TGF-b1, which are considered Smad4-independent target genes for TGF-b ( Figure 6, Table 1 ). In the WT cells, 116/3756 clones were upregulated and 39/ 3756 clones were downregulated; these may include The list includes those genes whose expression was upregulated >2-fold or downregulated o0.5-fold by TGF-b1. The 20 highest and the 20 lowest expressed genes are shown
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Smad4-dependent and -independent target genes of TGF-b ( Figure 6 , Table 2 ). In all, 22 clones were obtained from the S4KD and WT cells. Of these, nine clones were commonly upregulated and four clones were commonly downregulated; these clones were considered to be regulated in a Smad4-independent manner. The remaining nine clones were found to be inversely regulated between the S4KD and WT cells ( Figure 6 ). Based on a survey of published reports on the relationships between various molecules and TGF-b, including the previous microarray data on TGF-b signaling (Akiyoshi et al., 2001; Chen et al., 2001; Verrecchia et al., 2001; Zavadil et al., 2001) , we conclude that 246 of the identified genes have not been reported previously as genes that lie downstream of TGF-b1. In particular, we found 142 novel targets among the 187 Smad4-independent target molecules that were regulated by TGF-b1, which have not been previously reported, even in Smad4 intact cells.
We also performed proteomic analysis of the S4KD cells (Imamura et al., 2004) . The 12 previously identified target molecules of TGF-b1 showed no overlap with those identified in this study due to the fact that the arrayed genes screened were a small fraction of the whole genome, and also because, in part, the protein samples in the previous study were harvested after a 12-h incubation with TGF-b1; our RNA samples, however, were collected after 2 h of TGF-b1 stimulation. Moreover, discrepancies between mRNA and protein levels have been found in previous studies, which is indicative of the translational and post-translational regulation of each molecule (Gygi et al., 1999; Chen et al., 2002) .
Although the existence of a non-Smad pathway downstream of TGF-b has been demonstrated (Hartsough and Mulder, 1995; Engel et al., 1999; Hocevar et al., 1999; Bhowmick et al., 2001; Yu et al., 2002) , it has not been elucidated to the same extent as the Smad pathway. In the present study, the microarray data showed that TGF-b1 immediately up-or downregulated 4-5% of the 3756 arrayed genes in the Smad4 intact and Smad4-inactivated cells. This result suggests that the Smad4-dependent and -independent pathways are of Figure 5 Quantitative RT-PCR analysis of target genes for TGFb. The PANC-1-S4KD and WT cells were incubated with or without 10 ng/ml TGF-b1 for 2 h. Total RNA extraction, cDNA synthesis, and quantitative RT-PCR analysis were performed as described above. The ratio of the mRNA level of each gene to that of GAPDH was calculated, and the value of 1.0 was assigned to WT cells that were incubated without TGF-b1. All of the experiments were repeated twice in triplicate, and the mean and s.d. are shown. (a) Quantification of the genes that were obtained from the S4KD array. (b) Quantification of the genes that were obtained from the WT array. Dynein, dynein, axonemal, heavy polypeptide 2; SUMO-1AE, SUMO-1 activating enzyme subunit 2; NUP153, 153-kDa nucleoporin; CASP3, caspase-3; potassium channel, potassium large conductance calcium-activated channel, subfamily M, beta member 1; Bar, s.d. Figure 6 Targets of TGF-b signaling in the S4KD and Smad4 intact cells, as identified by microarray analysis. The PANC-1-S4KD and WT cell pools were incubated for 2 h in the presence or absence of 10 ng/ml TGF-b1, and total RNA was extracted. The fluorescent cDNA probes were prepared from each RNA sample, (i), (ii), (iii), (iv), and analysed by the microarray which consisted of 3756 distinct cDNA clones as described in Materials and methods. The analyses with probes (ii) and (i) were compared to detect clones that were putatively regulated in a Smad4-independent manner by TGF-b1. Comparison of the analyses with probes (iv) and (iii) identified clones that were putatively regulated by TGF-b1 in either a Smad4-dependent or -independent manner. Molecules that were modulated >2 or o0.5-fold by the stimuli were considered to be targets of TGF-b1. Of the 3756 arrayed genes, 187 from the S4KD cells and 155 from the WT cells were identified as targets of TGFb1. In all, 22 genes were obtained from the two cell types, including nine commonly upregulated, four commonly downregulated, and nine inversely regulated genes Gene expression profiles in Smad4 knockdown cells A Jazag et al comparative importance, based on the number of regulated genes.
Given our results, how is the TGF-b signal transmitted independently of Smad4? We propose two possible pathways. First, the signal may pass via the TbRI-Smad2/3 pathway. We have recently shown that p21/WAF1 may be upregulated by TGF-b in a Smad4-independent manner through TbRI-Smad2/3 signaling and not via the mitogen-activated protein kinase cascade . A novel, alternative CoSmad may be involved in this pathway. Second, a non-Smad pathway that transmits the signal in a Smad2/ 3/4-independent manner. In terms of non-Smad pathways, p38, c-Jun amino-terminal kinase, and Rho have been implicated in TGF-b-induced apoptosis, epithelialmesenchymal transition, cell motility, and cancer cell invasion (Bhowmick et al., 2001; Yu et al., 2002) .
Gene function profiles induced by TGF-b1 signaling in the S4KD and Smad4 intact cells
All of the target genes that were identified in the microarray were classified according to biological function ( Table 3 ). Molecules that are involved in signal transduction, transcription, and metabolism were frequently observed in both the S4KD and WT arrays. As shown in Table 3 , molecules that are associated with positive or negative cell proliferation showed different patterns of expression between the S4KD and WT cells. Unexpectedly, molecules related to positive cell proliferation were upregulated frequently in Smad4 intact cells, whereas these molecules were downregulated frequently in S4KD cells. This suggests that TGF-b may regulate target molecules that are involved in proapoptosis and growth inhibition, as well as those associated with antiapoptosis and growth stimulation, and thereby exert extensive control over complicated biological functions. The results are complex, because some of the genes that we classified as being involved in either positive or negative cell proliferation have been reported as being both proapoptotic and antiapoptotic, depending on the cell state; in addition, some of these genes have been reported exclusively in certain nonepithelial cell types. Table 3 shows that cell adhesion molecules were downregulated frequently, and that molecules that promote cell motility were upregulated frequently in S4KD cells in response to TGF-b1, which suggests that these cells may separate from the primary tumor and invade the surrounding tissues.
Moreover, inverse regulation patterns between the S4KD and WT cells were seen for nine genes, which included genes that are associated with cell adhesion, positive cell proliferation, and signal transduction. These target genes may be up-or downregulated by TGF-b1 via the Smad4 intact pathway, and may be inversely regulated due to Smad4 inactivation. The modulation of these target genes may produce the malignant characteristics of pancreatic cancer cells, although this remains to be investigated.
Cell migration induced by TGF-b1 was inhibited in the S4KD cells
In order to elucidate the phenotypic change that was due to the S4KD, we performed the following in vitro and in vivo assays. First, cell proliferation was examined using the MTT (methylthiazolyl diphenyl-tetrazolium bromide) and BrdU (5-bromo-2 0 -deoxyuridine) incorporation assays. A transwell cell invasion assay using a Matrigel-coated chamber (BD Biosciences, San Jose, CA, USA) was also performed. However, the results of these assays showed no significant differences between the S4KD and WT cells (data not shown). Then, we performed a more precise cell cycle analysis after synchronizing the cell phase using a modified thymidine block method. In brief, cells were incubated with 2.5 mM thymidine for 24 h, then after 14 h, they were incubated with 10 mg/ml aphidicolin for another 14 h, which synchronized most of the cells in the G1 phase. Then the cells were treated with or without 5 ng/ml TGF-b1 and S phase entry was analysed using flow cytometry. TGF-b1 clearly inhibited S phase entry not only in WT cells but also in S4KD cells, and the difference was not significant (data not shown).
Our attempts to implant these cells subcutaneously in nude mice and severely compromised immunodeficient (SCID) mice were unsuccessful. Then, we injected the cells into the spleens of nude and SCID mice to examine whether they could metastasize to the liver. On killing the mice after 6 weeks, no metastasis was found.
Finally, we performed an in vitro cell migration assay (wound closure assay) as described in Materials and methods. TGF-b is associated with cell migration in certain cell lines (Morton and Barrack, 1995; Dumont et al., 2003) . In this study, the WT cells also migrated rapidly with the stimuli, while the S4KD cells showed obviously delayed migration (Figure 7) . The count of the cells showed no difference in number between these cells. We performed the experiment five times, and the results were similar. Since PANC-1 (parental cells) also showed rapid migration, the delay due to S4KD was considered a phenotypic change due to the S4KD. In Table 3 Classification of TGF-b1-targeted genes in PANC-1-S4KD
and PANC-1-puro cells some cell lines, the TGF-b-induced migration was Smad-independent (Dumont et al., 2003) ; by contrast, the PANC-1 cell family demonstrated Smad4-dependent migration.
Following this, we performed quantitative RT-PCR analysis of the genes that were inversely regulated in the microarray, and found that integrin b7 (ITGB7), which is one of the integrin family, was upregulated by TGFb1 in WT cells, but downregulated in S4KD cells (Figure 8 ). The integrin family members are cell adhesion molecules, and have a dual effect promoting and preventing cell migration (Jin and Varner, 2004) . Certain subclasses of the family are upregulated by TGF-b (Xie et al., 2003) and so is ITGB7 in T cells (Lim et al., 1998) , although the exact function of ITGB7 in epithelial cells is not completely understood. Our study suggested that the regulation of ITGB7 plays a role in cell migration, although it remains unclear whether the inhibition of cell migration due to the loss of Smad4 function is be associated with the malignant character of pancreatic cancer.
As described above, we detected a number of distinct target genes in our study that were regulated downstream of the TGF-b signal. The significance and mechanism of TGF-b-induced regulation of each target gene should be investigated further in order to achieve a better understanding of pancreatic cancer. A comprehensive understanding of the intracellular dynamics of pancreatic cancer should lead to the development of novel therapeutic targets with clinical relevance.
Materials and methods
Cell culture
The pancreatic cancer cell line PANC-1 was purchased from the American Type Culture Collection (Rockville, MD, USA). It was maintained in Dulbecco's modified Eagle's medium (Sigma, St Louis, MO, USA) supplemented with 10% fetal bovine serum (Sigma) at 371C in a 5% CO 2 atmosphere.
Plasmids
The pcPUR þ U6icassette, pCMV5-Smad4-Flag, and (CAGA) 9 -luc plasmids were described previously (Dennler et al., 1998; Ijichi et al., 2001; Miyagishi and Taira, 2002; Yokota et al., 2003) . The pRL-SV40 vector (Promega, Madison, WI, USA), which contains the SV40 promoter upstream of the coding sequence of Renilla luciferase, was used as the internal control in the luciferase assay.
Transfection
Transfection into the cells was performed in this study using the transfection reagent Effectene (Qiagen, Hilden, Germany) according to the manufacturer's instructions.
Western blotting
Western blotting was performed as described previously (Ijichi et al., 2001) . The equal amounts of protein were electrophoresed and the Smad4 and b-actin proteins were detected with the anti-Smad4 antibody (BD Transduction Laboratories, Lexington, KY, USA) at a dilution of 1 : 250 or anti-b-actin antibody (Sigma) at a dilution of 1 : 2500.
Luciferase assay
The PANC-1-S4KD and WT cells were transfected with (CAGA) 9 -luc and pRL-SV40. After 24 h, the cells were incubated with or without 2.5 ng/ml TGF-b1 (R&D Systems, Minneapolis, MN, USA) for an additional 24 h, and the dual luciferase assay was performed as described previously (Ijichi et al., 2001) . The firefly luciferase activity of (CAGA) 9 -luc was normalized to the Renilla luciferase activity of pRL-SV40. The level of luciferase in cells in the absence of TGF-b1 was assigned a value of 1.0, and the relative activities were calculated. The experiments were performed twice in duplicate.
Quantitative RT-PCR
The PANC-1-S4KD and WT cell pools were incubated with or without 10 ng/ml of TGF-b1 for 2 h, and the total RNA was Figure 7 Cell migration assay on the S4KD and Smad4 intact cell lines. The cells were seeded and incubated with or without 5 ng/ml TGF-b1 for 24 h. Then, confluent cell monolayers were wounded by scraping, using a pipette tip with the same width, and the cell migration was observed at various times. Each experiment was repeated five times and the representative result is shown. Magnification: Â 40 Figure 8 Quantitative RT-PCR of integrin b7. Quantitative RT-PCR analysis of integrin b7 (ITGB7) was performed as described above. The ratio of the mRNA level of ITGB7 to that of GAPDH was calculated, and the value of 1.0 was assigned to WT cells that were incubated without TGF-b1. The experiments were repeated twice in triplicate, and the mean and s.d. are shown. Bar, s.d. extracted from these cells using ISOGEN (Nippon Gene, Tokyo, Japan). The cDNA templates were synthesized from 1 mg of total RNA using the ImProm-II TM Reverse Transcription System (Promega). Quantitative RT-PCR analysis was performed using the ABI 7000 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA), according to the manufacturer's instructions. The ratio of the mRNA level of each gene to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was calculated, and the value of 1.0 was assigned to the WT cells that were incubated without TGF-b1. Each experiment was repeated twice in triplicate. The primer sequences are shown in Supplementary Table 2 .
cDNA microarray
The PANC-1-S4KD and WT cell pools were incubated for 2 h in the presence or absence of 10 ng/ml TGF-b1, and total RNA was extracted. The following samples were obtained: (i) S4KD cells incubated without TGF-b1; (ii) S4KD cells stimulated with TGF-b1; (iii) WT cells incubated without TGF-b1; and (iv) WT cells stimulated with TGF-b1. The microarray procedure was performed using the Atlas Glass Array Human 3.8 II Microarray (Clontech, Palo Alto, CA, USA), according to the manufacturer's instructions. In brief, cDNA probes were prepared from 7 mg of the total RNA, and labeled with the fluorescent dye Cy3 (Amersham Biosciences, Uppsala, Sweden) using the PowerScript Reverse Transcription Kit (Clontech). The samples were then applied onto the microarray followed by incubation at 501C overnight under humid conditions. After washing, fluorescence images of the microarrays were scanned with a fluorescence laser confocal slide scanner (Affymetrix 428 Array Scanner; Affymetrix, Santa Clara, CA, USA). The Cy3 intensities with background subtraction were determined in each sample and the results were compared each other using ImaGene 4.2 software (BioDiscovery, Marina Del Rey, CA, USA). The comparison analysis was performed after normalization by the total Cy3 intensities. We repeated hybridizations four times per each sample and used the most reliable pair of hybridizations that showed high and almost equal total intensities in order to avoid a critical bias for the data. The analyses with probes (ii) and (i) were compared to detect clones that were putatively regulated in a Smad4-independent manner by TGF-b1.
Comparison of the analyses with probes (iv) and (iii) identified clones that were putatively regulated by TGF-b1 in either a Smad4-dependent or -independent manner. Molecules that were modulated >2-or o0.5-fold by the stimuli were considered to be targets of TGF-b1.
Cell migration assay (wound closure assay)
A total of 10 6 cells were seeded and incubated with or without 5 ng/ml TGF-b1 for 24 h. Then confluent cell monolayers were wounded by scraping, using a pipette tip with the same width, and the cell migration was carefully observed at various times. Each experiment was repeated five times.
